Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Asthma (16)
  • x Biologicals (5)
  • Biomarkers (3)
  • COVID19 (1)
  • Environmental allergy and climate change (1)
  • Immune deficiencies and autoimmunity (2)
  • Infections (3)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (2)
  • Pediatrics (10)
Poster available until
Poster categories
keywords
Session Reference
  • L-TPS02 (10)
  • L-TPS07 (11)
  • L-TPS08 (2)
  • L-TPS09 (4)
  • L-TPS10 (1)
  • L-TPS15 (4)
  • L-TPS19 (1)
  • L-TPS20 (12)
  • L-TPS21 (1)
  • TPS02 (2)
  • TPS06 (8)
  • TPS09 (2)
  • TPS15 (10)
  • TPS17 (4)
  • TPS18 (9)
  • TPS21 (1)
  • TPS28 (1)
  • TPS29 (1)
  • TPS38 (13)
  • TPS39 (13)
  • TPS51 (1)
  • TPS52 (14)
  • TPS53 (6)
  • TPS55 (10)
  • x TPS56 (5)
  • TPS57 (2)
  • TPS63 (1)
  • TPS64 (11)
  • TPS66 (1)
  • TPS67 (9)
  • TPS68 (3)
  • TPS69 (2)
5 results
Thumbnail

- D3.114 - Does severe asthma exist in preschool children?

Thumbnail

- D3.116 - Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis

Thumbnail

- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thumbnail

- D3.119 - Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype

Thumbnail

- D3.123 - Dupilumab: Improved Asthma Control and Quality of Life in Pediatric Patients - A Real-World, Single-Center Study

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM